Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05144542 · ClinicalTrials.gov registry record · NA

Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer

A NA study of Lung Carcinoma, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
140
Enrollment target
1
Study location

NCT05144542: Active NA study of Lung Carcinoma, sponsored by M.D. Anderson Cancer Center.

NCT05144542 is a NA study of Lung Carcinoma that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 140 participants, below the 5,040-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05144542, a NA study of Lung Carcinoma, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
140 participants
Enrollment target
1
Study location

Study Summary

This clinical trial investigates the effects of switching from smoking regular cigarettes to electronic cigarettes (e-cigarettes) among older adult smokers at high risk for lung cancer. E-cigarettes use heated vapor to deliver nicotine. Information gained from this trial may help inform regulators of the potential risks and benefits of switching smokers at high risk for lung cancer to electronic cigarettes. This research also may help inform the Food and Drug Administration (FDA) how best to regulate e-cigarettes with the goal of improving public health.

Conditions Studied

Lung Carcinoma

Interventions

  • OTHER Questionnaire Administration
  • DRUG Nicotine Replacement
  • PROCEDURE Participants smoke their usual brand of cigarettes for 26 weeks.
  • PROCEDURE Participants will vape electronic cigarettes for 26 weeks.

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2022-03-07
Est. Completion 2026-10-17
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05144542

The ClinicalTrials.gov registry entry for NCT05144542 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,040-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (97% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.

NCT05144542 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05144542 about?

NCT05144542 is a clinical study titled "Risk and Benefits of Electronic Cigarettes to Older Smokers at High Risk for Lung Cancer". This clinical trial investigates the effects of switching from smoking regular cigarettes to electronic cigarettes (e-cigarettes) among older adult smokers at high risk for lung cancer. E-cigarettes use heated vapor to deliver nicotine. Information gained from this trial may help inform regulators o...

What is the current status of trial NCT05144542?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2022-03-07. Estimated completion is 2026-10-17.

What conditions does trial NCT05144542 study?

This clinical trial studies the following conditions: Lung Carcinoma.

What interventions are being tested in trial NCT05144542?

The interventions under investigation include: Questionnaire Administration (OTHER), Nicotine Replacement (DRUG), Participants smoke their usual brand of cigarettes for 26 weeks. (PROCEDURE), Participants will vape electronic cigarettes for 26 weeks. (PROCEDURE).

Who is sponsoring clinical trial NCT05144542?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05144542 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Carcinoma

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.